David Freedman
Principal investigator, leads NANOVIEW BIOSCIENCES, INC..
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$1.4MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $1.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 15, 2018 | NSF | SBIR Phase II SBIR Phase II: High-Throughput and Scalable Nanoparticle Characterization for Life Sciences Applications | $934K | NANOVIEW BIOSCIENCES, INC. |
| Jun 1, 2017 | NSF | SBIR Phase I SBIR Phase I: High-Throughput Nanoparticle Characterization for Life Sciences Applications | $225K | NANOVIEW BIOSCIENCES, INC. |
| May 2, 2017 | NIH | SBIR Phase I A Scalable Blood-based Pancreatic Cancer Test for High-Risk Screening | $227K | NANOVIEW BIOSCIENCES, INC. |
Peer ranks
Federal funding#1,758
Awards as PI#927
Patents#505
Companies
- NANOVIEW BIOSCIENCES, INC.Leads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.